In accordance to its targeted timeline, Cepheid CPHD recently launched its Xpert BCR-ABL Ultra test commercially outside the U.S. The company will initiate shipment of this test as a CE-IVD product ...
ARIAD Pharmaceuticals, Inc.Kendra Adams, 617-503-7028orLiza Heapes, 617-621-2315orKatherine Clock, 503-459-4974 and (NASDAQ: ARIA) today announced that MolecularMD has voluntarily withdrawn its ...
Oncoguide System: A computerized interactive assistance system for the diagnosis and treatment of CML/MPN and MDS D. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
In vitro diagnostic may be used to monitor disease progression and therapy in Ph+ CML patients. Asuragen and Life Technologies obtained a CE-mark and have launched the BCR/ABL1 Quant™ Test in Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback